Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDImpel Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Impel Pharmaceuticals Inc. Earnings Date And Information
Impel Pharmaceuticals Inc. last posted its earnings results on Tuesday, November 14th, 2023. The company reported $-0.58 earnings per share for the quarter, missing analysts' consensus estimates of $-0.36 by $0.22. The company had revenue of 5.02 M for the quarter and had revenue of 12.65 M for the year. Impel Pharmaceuticals Inc. has generated $-6 earnings per share over the last year ($-5.52 diluted earnings per share) and currently has a price-to-earnings ratio of -0.04. Impel Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Impel Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2023 | Q3 2023 | -$0.36 | -$0.58 | -0.22 | $8.00 M | $5.02 M |
| 08/18/2023 | Q2 2023 | -$0.65 | -$0.31 | 0.34 | $6.58 M | $6.58 M |
| 05/12/2023 | Q1 2023 | -$0.90 | -$1.63 | -0.73 | N/A | $4.37 M |
| 03/27/2023 | Q4 2022 | N/A | -$1.53 | N/A | N/A | $5.01 M |
| 11/14/2022 | Q3 2022 | -$0.87 | -$1.73 | -0.86 | N/A | $3.08 M |
| 08/15/2022 | Q2 2022 | -$1.13 | -$1.27 | -0.14 | $1.80 M | $2.80 M |
| 05/16/2022 | Q1 2022 | -$1.08 | -$1.35 | -0.27 | N/A | $1.76 M |
| 03/29/2022 | Q4 2021 | N/A | -$1.07 | N/A | N/A | $577,000 |
| 11/15/2021 | Q3 2021 | -$0.82 | -$1.24 | -0.42 | $76 | $91,000 |
| 08/16/2021 | Q2 2021 | -$0.59 | -$1.10 | -0.51 | N/A | $0 |
| 06/07/2021 | Q1 2021 | -$0.93 | -$0.58 | 0.35 | N/A | $0 |
| 12/30/2020 | Q4 2020 | N/A | -$1.07 | N/A | N/A | $0 |
| 09/29/2020 | Q3 2020 | N/A | -$0.69 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$0.98 | N/A | N/A | $0 |
| 03/30/2020 | Q1 2020 | N/A | -$0.74 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Impel Pharmaceuticals Inc. Earnings: FAQ's
The conference call for Impel Pharmaceuticals Inc.'s latest earnings report can be listened to online.
The conference call transcript for Impel Pharmaceuticals Inc.'s latest earnings report can be read online.
Impel Pharmaceuticals Inc. (:IMPL) has a recorded annual revenue of $12.65 M.
Impel Pharmaceuticals Inc. (:IMPL) has a recorded net income of $-129,440,000.Impel Pharmaceuticals Inc. has generated $-5.52 earnings per share over the last four quarters.
Impel Pharmaceuticals Inc. (:IMPL) has a price-to-earnings ratio of -0.04 and price/earnings-to-growth ratio is -0.